| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |